Brain, Vol. 124, No. 10, 2014-2027,
October 2001
© 2001 Oxford University Press
In vivo visualization of activated glia by[11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion
1 MRC Cyclotron Unit, Imperial College, Faculty of Medicine, Hammersmith Hospital, 2 Department of Neuropathology and Psychiatry, Imperial College, Faculty of Medicine, Charing Cross Hospital, 3 St Thomas' Hospital, London, 4 MRC Cognition and Brain Sciences Unit, Cambridge, UK and 5 Department of Neuromorphology, Max Planck Institute for Neurobiology, Martinsried, Germany
Correspondence to:
Richard B. Banati, MD, MRC Cyclotron Unit, Imperial College, Faculty of Medicine, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK E-mail: richard.banati{at}csc.mrc.ac.uk
A major challenge in the assessment of brain injury and its relationship to the ensuing functional deficits is the accurate delineation of the areas of damage. Here, we test the hypothesis that the anatomical distribution pattern of activated microglia, a normally dormant population of resident brain macrophages, can be used as a surrogate marker of neuronal injury not only at the primary lesion site but also in the antero- and retrograde projection areas of the lesioned neurones. Two patients with asymmetrical herpes simplex encephalitis were serially scanned 6 and 12 months after the acute illness using PET with [11C] (R)-PK11195, a marker of activated microglia/brain macrophages. The evolving structural changes in the brain were measured by volumetric MRI and compared with the pattern of [11C](R)-PK11195 binding. Corresponding to the clinically observed cognitive deficits, quantitative [11C](R)-PK11195-PET revealed highly significant signal increases within the affected limbic system and additionally in areas connected to the limbic system by neural pathways, including the lingual gyrus in the occipital lobe and the inferior parietal lobe, which had normal morphology on structural MRI. The increased [11C](R)-PK11195 binding, signifying the presence of activated microglia, persisted many months (>12) after antiviral treatment. Cortical areas that showed early high [11C](R)-PK11195 binding subsequently underwent atrophy. These observations demonstrate that in vivo imaging of activated microglia/brain macrophages provides a dynamic measure of active tissue changes following an acute focal lesion. Importantly, the glial tissue response in the wake of neuronal damage is protracted and widespread within the confines of the affected distributed neural system and can be related to the long-term functional deficits.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Pavese, A. Gerhard, Y. F. Tai, A. K. Ho, F. Turkheimer, R. A. Barker, D. J. Brooks, and P. Piccini Microglial activation correlates with severity in Huntington disease: A clinical and PET study Neurology, June 13, 2006; 66(11): 1638 - 1643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E.K. Herrmann, K. Hahn, C. Kratzer, I. von Seggern, C. Zimmer, and E. Schielke Status Epilepticus as a Risk Factor for Postencephalitic Parenchyma Loss Evaluated by Ventricle Brain Ratio Measurement on MR Imaging AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1245 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-K. Chen and T. R. Guilarte Imaging the Peripheral Benzodiazepine Receptor Response in Central Nervous System Demyelination and Remyelination Toxicol. Sci., June 1, 2006; 91(2): 532 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Cagnin, S D Taylor-Robinson, D M Forton, and R B Banati In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy Gut, April 1, 2006; 55(4): 547 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. de Jong, I. M. Dijkstra, M. Hensens, N. Brouwer, M. van Amerongen, R. S. B. Liem, H. W. G. M. Boddeke, and K. Biber Vesicle-Mediated Transport and Release of CCL21 in Endangered Neurons: A Possible Explanation for Microglia Activation Remote from a Primary Lesion J. Neurosci., August 17, 2005; 25(33): 7548 - 7557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Versijpt, J C Debruyne, K J Van Laere, F De Vos, J Keppens, K Strijckmans, E Achten, G Slegers, R A Dierckx, J Korf, et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study Multiple Sclerosis, April 1, 2005; 11(2): 127 - 134. [Abstract] [PDF]
|
|
|
|
 |
|
 R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson Role of Microglia in Central Nervous System Infections Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-K. Chen, K. Baidoo, T. Verina, and T. R. Guilarte Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization Brain, June 1, 2004; 127(6): 1379 - 1392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. B. Dickerson, J. J. Boronow, C. Stallings, A. E. Origoni, I. Ruslanova, and R. H. Yolken Association of Serum Antibodies to Herpes Simplex Virus 1 With Cognitive Deficits in Individuals With Schizophrenia Arch Gen Psychiatry, May 1, 2003; 60(5): 466 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B Banati Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain Br. Med. Bull., March 1, 2003; 65(1): 121 - 131. [Abstract] [Full Text] [PDF]
|
|